Overview

Comparison of Insulin Mix25 Versus Mix50

Status:
Completed

Trial end date:
2014-08-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine the efficacy and safety of insulin Lispro Mix25 (LM25) compared to insulin Lispro Mix50 (LM50) as an insulin starter in participants with Type 2 diabetes mellitus (T2DM).

Phase:

Phase 4

Details

Lead Sponsor:

Eli Lilly and Company

Treatments:

Insulin
Insulin Lispro
Insulin, Globin Zinc